Atlas Trials

Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine

Clinical trial NCT02281591 · COMPLETED

Trial details

NCT number
NCT02281591
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2006-06-01
Primary completion
2006-07-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.